Bone marrow-derived Ly6C− macrophages promote ischemia-induced chronic kidney disease
2019 · Cell Death and Disease · 59 citations
https://doi.org/10.1038/s41419-019-1531-3
X
Xuan Deng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
69
Papers
2.0K
Citations
15
h-index
21
i10-index
Xuan Deng is an academic researcher from Merck & Co., Inc., Rahway, NJ, USA (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Pancreatic and Hepatic Oncology Research. The author has an h-index of 15, co-authored 59 publications.
ORCID: 0000-0002-4382-5665Papers by this author
worksBlocking connexin 43 and its promotion of ATP release from renal tubular epithelial cells ameliorates renal fibrosis
2022 · Cell Death and Disease · 53 citations
https://doi.org/10.1038/s41419-022-04910-w
MOESM3 of Building a multipurpose insertional mutant library for forward and reverse genetics in Chlamydomonas
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3780041_d3
MOESM2 of Building a multipurpose insertional mutant library for forward and reverse genetics in Chlamydomonas
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3780041_d2
An alternative method for inferring Pandy's test using cerebrospinal fluid total protein
2024 · Practical Laboratory Medicine · 0 citations
https://doi.org/10.1016/j.plabm.2024.e00411
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat